Literature DB >> 20797756

IL-6-mediated intersubgenotypic variation of interferon sensitivity in hepatitis C virus genotype 2a/2b chimeric clones.

Goki Suda1, Naoya Sakamoto, Yasuhiro Itsui, Mina Nakagawa, Megumi Tasaka-Fujita, Yusuke Funaoka, Takako Watanabe, Sayuri Nitta, Kei Kiyohashi, Seishin Azuma, Sei Kakinuma, Kiichiro Tsuchiya, Michio Imamura, Nobuhiko Hiraga, Kazuaki Chayama, Mamoru Watanabe.   

Abstract

Mechanisms of difference in interferon sensitivity between hepatitis C virus (HCV) strains have yet to be clarified. Here, we constructed an infectious genotype2b clone and analyzed differences in interferon-alpha sensitivity between HCV-2b and 2a-JFH1 clones using intergenotypic homologous recombination. The HCV-2b/JFH1 chimeric virus able to infect Huh7.5.1 cells and was significantly more sensitive to IFN than JFH1. IFN-induced expression of MxA and 25-OAS was significantly lower in JFH1 than in 2b/JFH1-infected cells. In JFH1-infected cells, expression of SOCS3 and its inducer, IL-6, was significantly higher than in 2b/JFH1-infected cells. The IFN-resistance of JFH1 cells was negated by siRNA-knock down of SOCS3 expression and by pretreatment with anti-IL6 antibody. In conclusion, intergenotypic differences of IFN sensitivity of HCV may be attributable to the sequences of HCV structural proteins and can be determined by SOCS3 and IL-6 expression levels.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20797756     DOI: 10.1016/j.virol.2010.07.041

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91.

Authors:  Yusuke Funaoka; Naoya Sakamoto; Goki Suda; Yasuhiro Itsui; Mina Nakagawa; Sei Kakinuma; Takako Watanabe; Kako Mishima; Mayumi Ueyama; Izumi Onozuka; Sayuri Nitta; Akiko Kitazume; Kei Kiyohashi; Miyako Murakawa; Seishin Azuma; Kiichiro Tsuchiya; Mamoru Watanabe
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

2.  Inhibitory effect of a triterpenoid compound, with or without alpha interferon, on hepatitis C virus infection.

Authors:  Takako Watanabe; Naoya Sakamoto; Mina Nakagawa; Sei Kakinuma; Yasuhiro Itsui; Yuki Nishimura-Sakurai; Mayumi Ueyama; Yusuke Funaoka; Akiko Kitazume; Sayuri Nitta; Kei Kiyohashi; Miyako Murakawa; Seishin Azuma; Kiichiro Tsuchiya; Shinya Oooka; Mamoru Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

3.  Production of infectious chimeric hepatitis C virus genotype 2b harboring minimal regions of JFH-1.

Authors:  Asako Murayama; Takanobu Kato; Daisuke Akazawa; Nao Sugiyama; Tomoko Date; Takahiro Masaki; Shingo Nakamoto; Yasuhito Tanaka; Masashi Mizokami; Osamu Yokosuka; Akio Nomoto; Takaji Wakita
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

Review 4.  Novel Treatment of Hepatitis C Virus Infection for Patients with Renal Impairment.

Authors:  Goki Suda; Koji Ogawa; Megumi Kimura; Masato Nakai; Takuya Sho; Kenichi Morikawa; Naoya Sakamoto
Journal:  J Clin Transl Hepatol       Date:  2016-12-26

5.  The Us2 Gene Product of Herpes Simplex Virus 2 modulates NF-κB activation by targeting TAK1.

Authors:  Xuan Lu; Changjing Huang; Yi Zhang; Yong Lin; Xueyu Wang; Qian Li; Shi Liu; Jingfeng Tang; Li Zhou
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

6.  The IL-6/STAT3 pathway upregulates microRNA-125b expression in hepatitis C virus infection.

Authors:  Chia-Yen Dai; Yi-Shan Tsai; Wen-Wen Chou; Tawei Liu; Chung-Feng Huang; Shu-Chi Wang; Pei-Chien Tsai; Ming-Lun Yeh; Ming-Yen Hsieh; Ching-I Huang; Shang-Yin Vanson Liu; Jee-Fu Huang; Wan-Long Chuang; Ming-Lung Yu
Journal:  Oncotarget       Date:  2018-01-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.